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Nursing considerations for supporting cancer patients, with metastatic spinal cord compression:  
a literature review. 
  
Abstract 
Background:  Metastatic Spinal Cord Compression (MSCC) is an oncology emergency.  
Prevalence is increasing.  Treatment and care are complex and those diagnosed may be faced 
with life changing challenges.   
Aims:  To review the impact and management of MSCC in patients with cancer, in order to 
analyse nursing considerations for supporting patients.  
Methods:  A literature review and thematic analysis of 5 primary research papers, published 
between 2009 and 2014.  
Findings:  Two themes of prognosis/survival time and independence vs. dependence were 
discovered.  
Conclusion:  The onset of MSCC may result in paralysis and associated loss of independence, 
impacting upon a patient’s quality of life.  Understanding individuals’ prognosis and 
treatment/care preferences is fundamental for the sensitive, individualised support of patients 
with MSCC.  The findings reinforce the nurses’ role in health education, in order to raise 
awareness of MSCC and promote early diagnosis so that patients maintain function and 
independence as along as possible.  The findings support the need for nurses to be equipped 
with appropriate communication skills to initiate and engage in sensitive, difficult and pro-active 
conversations with patients and their families, supporting the delivery of humanised care. 
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Key phrases: 
Metastatic spinal cord compression (MSCC) may be a life changing complication of advanced 
cancer and an oncology emergency.  
Early diagnosis of MSCC can preserve neurological function but diagnosis is common after the 
onset of neurological symptoms.   
Health education could help to facilitate early diagnosis of MSCC. 
Understanding the impact of prognosis/survival time and independence versus dependence, 
enables nurses to engage with patients in a humanising way, using meaningful communication 
in order to empower them and support their choices.  
 
Introduction 
Metastatic spinal cord compression (MSCC) may be a life changing complication of advanced 
cancer and an oncology emergency (Al-Qurainy and Collis, 2016; Bowers, 2015).  MSCC, is 
defined as compression of the spinal cord or cord equina by metastatic or direct spread of a 
malignancy to the vertebrae (National Institute for Health and Care Excellence, 2018; Farrell, 
2013).  It is an oncology emergency since it may cause neurological impairment, but prompt 
treatment while the patient remains ambulant results in maintenance of the ability to walk in 80-
100% of cases (London Cancer, 2012).  
 
Whilst spinal cord compression may be non-malignant in origin and present in people with or 
without cancer, MSCC can be the first presentation of an undiagnosed primary cancer which 
has progressed, or may reflect secondary disease (Wanman et al., 2017).  Any cancer has the 
potential to metastasise to the spine, but MSCC most commonly presents in breast, lung and 
prostate cancer, lymphoma and myeloma.  Advances in cancer treatment have resulted in 
higher long-term survival rates after cancer, therefore the risk of developing MSCC is increasing 
(Bowers, 2015; Spratt et al., 2017).   Signs of MSCC centre on spinal pain and neurological 
symptoms as summarised in figure 1. 
 
Spinal pain in the middle (thoracic) or upper 
(cervical) spine 
Progressive lower (lumbar) spinal pain 
Severe unremitting lower spinal pain 
Spinal pain aggravated by straining  
Localised spinal tenderness 
Nocturnal spinal pain preventing sleep. 
Neurological  symptoms   
Radicular pain 
Any limb weakness 
Difficulty walking 
Sensory loss or bladder or bowel dysfunction 
Signs of spinal cord or cauda equina 
compression. 
Figure 1.  Signs and symptoms of MSCC, in patients with cancer (NICE, 2008) 
 
Diagnosis of MSCC is by whole spine MRI, unless contraindicated.  Definitive treatment should 
be initiated as soon as possible and within 24 hours where neurological symptoms or signs 
suggest MSCC (NICE, 2008).  Definitive treatment of MSCC may include pain control, 
bisphosphonates, corticosteroids, kyphoplasty and vertebroplasty, radiotherapy, surgery, or 
supportive care including rehabilitation and community support, or palliative care (NICE, 2008). 
 
Presentation of MSCC commonly follows the onset of neurological symptoms, with the potential 
for paraparesis (a partial paralysis of the lower limbs), or permanent paraplegia (an impairment 
in motor or sensory function of the lower extremities) and associated complications, such as 
bowel, bladder and sexual dysfunction and prognosis is poor.  Loss of mobility and function due 
to MSCC commonly impacts on quality of life (Kaplow, 2016).  This work explores the impact of 
MSCC, in order to analyse the role of the nurse in supporting individuals.    
  
Method and search strategy 
The search used keywords, precisely focused to the question (see figure 2).  Contextually 
synonymous keywords were included to extend the breadth of available literature.  Search 
results were returned in CINAHL Complete, MEDLINE Complete and PSYCH Info.   
   
(‘’MM Spinal Cord Compression’’) AND (management OR treatment OR intervention OR 
therap* OR diagnos*) AND (oncology OR cancer OR malignancy OR tumour OR tumor OR 
metasta*).  
 Figure 2. Search terms. 
  
The search returned 311 records.  After applying inclusion and exclusion criteria (see figure 3), 
the remaining 29 full-text papers were accessed, read in full and discarded if they did not 
directly answer the research question. Ultimately, 5 original papers, clearly focused on the 
question, were systematically analysed and scored, using Critical Skills Appraisal Programme 
checklists, serving to strengthen the validity, reliability and transparency of the research process 
(CASP, 2018).   Papers with a score of 9 or above were considered to be appropriate for 
inclusion in the literature review. 
Inclusion criteria:         
Research with adult patients 
Peer-reviewed primary research papers 
Papers written in the English language 
International papers where 
transferable/generalisable to UK practice 
Exclusion criteria:        
Papers published more than a decade ago 
Papers with a wholly surgical or medical 
focus 
Papers focusing on an elderly population 
 
Figure 3.  Inclusion and exclusion criteria. 
 
Data from each paper were plotted to enable thematic analysis.  The process involved 
becoming familiar with the data, searching for themes and writing up the results. 
 
Author(s). Date. Sample characteristics Design Data Collection 
Fattal, C. et al. 2009 26 adult patients with spinal 
metastases treated within 4 Physical 
Medicine and Rehabilitation (PM&R) 
centres in France 
Quantitative Retrospective  chart 
review 
Warnock, C. 
and Tod, A. 
2014 10 inpatients, newly diagnosed with 
MSCC, with difficulty mobilising, 
Qualitative Semi-structured 
interviews  




At the time of a randomised audit of 50 charts (out of 150 admissions in one year), for patients 
who received radiotherapy for MSCC in a UK regional cancer centre, 90% (n=45) had died 
admitted for radiotherapy treatment.  
Eva, G. et al. 2009 2 female and 7 male patients, aged 
between 42-82, with MSCC, arising 
from a range of primary cancers. 
Qualitative Semi-structured 
interviews. 
Guo, Y. et al. 2010 87 adult patients, with MSCC, who 
required a physical medicine and 
rehabilitation consultation, in 
America 









2008 Randomised sample of 50 adult 
patients who received radiotherapy 
for MSCC in 2005 at a regional 
cancer centre 
 
Sample of 21 Consultants, 14 
Specialist Registrars and 107 nurses 














(Warnock et al 2008).  In 22% of cases (n=11) the diagnosis of cancer was made at the time of 
presentation with MSCC.  In 14% of cases (n=7) the patient died before they could be 
discharged.  The average length of stay was 13 days (range 6-48 days) with longer stays for 
patients who developed problems requiring further treatments.  The mean time between 
admission with MSCC and death in the research sample was 58.6 days (range 2-319 days).  
This data reinforces the potential for MSCC to be a presenting symptom of undiagnosed cancer 
and the poor prognosis associated with it. 
  
A retrospective chart review of 26 patients across 4 Specialist Physical Medicine and 
Rehabilitation (PMR) centres in France, over 5 years, explored impacts of rehabilitation care in 
patients with MSCC paraplegia, using measures including survival time.  In 53% of cases 
(n=14), patients were deceased, with their mean survival rate post-paraplegia 12.7 months 
(range 3-38 months)  (Fattal et al 2008).  The majority (86%) of patients (n=12) who died had 
spent more than a third of their time in the centre after diagnosis.  There was 1 patient lost to 
follow-up.  The 42% patients (n=11) who were alive at the time of the study had a mean survival 
time of 21.1 months.  Rehabilitation care plans and interventions were found to increase 
functional aptitudes in 65% of patients (n=18).  Crucially however, the time spent in the 
rehabilitation centre (average 161 days) was deemed to be too long in comparison to the 
patient’s prognosis with the drawbacks of reduced time with family and loved ones outweighing 
the benefits.  This data reinforces the potential to improve function through rehabilitation 
interventions, however these need to be balanced against prognosis.      
 
A retrospective chart review of 87 patients with MSCC, attending a rehabilitation consultation at 
an American cancer centre revealed that 100% of patients had impaired function, with 83% 
(n=72) requiring assistance with walking (Guo et al. 2010).  At the time of the study 68% (n=59) 
of patients had died, with a median survival time of 4.3 months.  Of these patients, 15% (n=13) 
had a ‘do not resuscitate’ order in place prior to their consultation and 44% (n=26) had DNR 
orders issued by their consultant at the centre.  The median time from the DNR issue by their 
consultant, where in place, to death, was 16.5 days (range 6.5-38.3 days).  The data supports 
that a sharp decline in function associated with MSCC is clearly linked to poor prognosis and 
should support practitioners to engage in communication about end-of-life choices.   
  
Focusing on the experiences, concerns and priorities of patients, Warnock and Tod (2014) 
interviewed 10 patients with a recent diagnosis of MSCC (range 9-24 days since diagnosis), 
who had received palliative radiotherapy.  Mobility was compromised in all cases with 90% 
(n=9) of patients immobile and 10% (n=1) with limited mobility. A theme of ‘thinking through the 
implications of MSCC’ included the concern of ‘how will my cancer progress?’.   Participants 
expressed understanding the extent of their cancer and ‘relatively poor prognosis’ (Warnock and 
Tod 2014).  Whilst concerns predominantly focused on the physical impact of MSCC, some 
patients expressed frustration at apparent delays in diagnosing MSCC, having sought medical 
advice in the previous 1-6 months.  In some cases this provoked anger and in others concern.  
Patients expressed uncertainty about their prognosis and about how much their mobility would 
improve, linked to how they (and their family) would cope functionally.  The data support that 
late diagnosis is associated with poor prognosis, with some concern about the skills of 
physicians to diagnose early signs of MSCC, that  might slow the onset of neurological 
symptoms.    
 
The data in this theme reinforces the poor prognosis of a diagnosis of MSCC, particularly once 
neurological symptoms are present.  Medical and nursing support and rehabilitation care may 
help to enhance functional capability, however the time required to achieve this can be to the 
detriment of time spent with family and loved ones.  Patients understand the poor prognosis 
associated with MSCC, therefore referring them to palliative care services and engaging in 
discussions about end of life care as functional ability decreases can help them to maintain 
some control and to express choices for their care.         
  
Independence vs Dependence  
Independence is predominantly focused on mobility, however it can also be impacted by bowel 
and bladder dysfunction.  Within the studies reviewed, a significant number of patients had lost 
their mobility at the time of diagnosis; 92% (n=24) were paraplegic or had paraparesis in Fattal 
et al’s (2009) study, 90% (n=9) in Warnock and Tod’s (2014) study were immobile and in Guo et 
al’s (2010) study 83% (n=72) of patients were immobile.  The reduction or loss of mobility 
caused patients sadness and made them concerned about their ability to manage at home and 
to get out the house when they wanted to (Warnock and Tod, 2014).  They also expressed 
frustration that their attempts to raise concerns had not resulted in an earlier diagnosis of 
MSCC, that might have preserved mobility. 
 
Warnock et al (2008) explored mobility and bowel/bladder related nursing care practices of 
patients diagnosed with MSCC in their audit, triangulated with retrospective chart data of the 
patients.  They discovered that 69% (n=74) of nurses routinely nursed patients on flat bed rest 
throughout their radiotherapy treatment, however only 10% (n=5) had documented spinal 
instability and 16% (n=8) had a documented reason for bedrest.  In relation to bowel and 
bladder care, 81% (n=87) nurses felt care was insufficient.  There was a reported failure to 
routinely initiate trial without urinary catheter following radiotherapy treatment and only 34% 
(n=36) nurses felt competent to teach patients intermittent self-catheterisation.  Additionally, 
only 44% of nurses felt competent carrying out digital rectal evaluation of faeces.  The data 
suggests that nursing care practices impact upon independence/dependence experienced by 
patients with MSCC.  In 36% (n=18) patients, this resulted in documented psychosocial concerns, 
linked to loss of independence.         
 
In a qualitative study, exploring the constructions of disability of patients’ with MSCC, patients 
discussed their dependence and stated their need to restructure their activities of daily living 
(ADLs) and consider physical adaptations to their home, with a view to increasing their 
independence.  Patients reported that morbidities of MSCC (bowel and bladder dysfunction, 
pain, mobility and fatigue), had been ‘managed well’ by nurses.  However, they felt that nurses 
were not supporting them to develop self-management skills and were therefore failing to help 
them be independent (Eva et al 2009).   
 
In contrast, healthcare professionals have been viewed as key in supporting patients to develop 
new skills and test their limits to improve function and independence (Warnock and Tod 2014).  
Rehabilitation care plans have proven to be helpful in identifying patient goals and supporting 
independence with the activities of daily living and the ability to manage transfers (Fattal et al. 
2009) where 66% (n=17) of patients experienced a significant increase in their overall functional 
aptitudes as a result of rehabilitation care plans.  However, the time spent as an inpatient to 
increase function and independence was to the detriment of time spent with family and loved 
ones.  In view of the poor prognosis associated with MSCC an alternative is the use of care 
packages, including palliative care services, enabling patients to be discharged home, or to 
other care settings, including hospice care (Warnock et al. 2008).      
  
The theme of independence versus dependence is significant for patients presenting with 
MSCC. Most of the patients in the research reviewed had some degree of dependence, most 
receiving a diagnosis of MSCC on admission to hospital.  This may not always be the case 
since prompt/early diagnosis and treatment of MSCC can help to preserve function and 
independence for as long as possible.  Nurses have a moral and professional responsibility to 
support and educate patients to develop self-management skills that will facilitate their 
independence.  The provision of care packages can support patients to return home in some 
cases or can support them to remain as independent as possible, for as long as possible.     
   
Discussion 
The themes of prognosis/survival time and independence vs dependence have emerged in this 
literature review.  Diagnosis of MSCC is often after the onset of neurological symptoms, with 
many patients presenting with loss of mobility and neurological symptoms, when prognosis is 
poor. A possible causal factor of this is a lack of prophylactic information given to patients 
regarding the signs and symptoms of MSCC (Hutchison et al., 2012), even though early 
intervention with surgical or medical intervention can reduce morbidity, particularly when 
combined with rehabilitation interventions (Guo et al., 2003; Fattal et al., 2011).  Since early 
diagnosis is crucial to maintaining as much function and independence as possible, the 
imperative appears to be health education, for those at risk (National Institute for Health and 
Care Excellence, 2018).   
  
Hutchison et al. (2012) reinforce the importance of patient education, at every step of the cancer 
journey.  This is a moral and professional imperative (NMC, 2018).  Personal experience of one 
author as a patient reveals significant information sharing at diagnosis and during active 
treatment.  Discussions about potential secondary disease are a sensitive issue and there is 
evidence that there is an absence of specific education about potential symptoms of secondary 
cancer, including MSCC (Hutchison et al, 2012).  Cancer Research UK (2018) reinforce the 
urgency of reporting signs of MSCC, but this information is hidden within publications about 
secondary bone cancer.  Information is available to the public through specific NICE guidelines 
(NICE, 2008) but without knowing the potential risk and symptoms of MSCC, patients cannot 
access information at the relevant time, that would enable them to seek appropriate treatment.  
Hutchison et al. (2012) highlight that patients (who are most likely to notice the early signs of 
MSCC) would like prophylactic information about MSCC.  The question is when to deliver such 
information.  The earliest point is at time of diagnosis with bone secondaries, but the point of 
discharge from services (usually around 10 years) would be an appropriate opportunity to 
educate patients about spinal pain, linked to MSCC.  After discharge, the onus is on patients to 
notice and report symptoms.  Understanding the signs of MSCC, may facilitate prompt GP 
referral, if the patient should experience them.  
  
The key prognostic indicator for functional outcome in MSCC is mobility status at presentation 
(Drudge-Coates and Rajbabul, 2008).  A secondary factor is the presence of neurological 
symptoms.  Spinal pain is the first indicator of MSCC.  Hutchison et al (2012) propose that 
educating cancer patients about the importance of highlighting spinal pain to their GP, 
especially in the presence of other neurological symptoms such as pins and needles or poor 
bladder control, will promote earlier diagnosis, that may enable treatment to take place before 
the onset of paralysis.  The question is when to provide education about MSCC.  Certainly, it is 
advocated that specific health education about MSCC is undertaken if a patient with breast, 
lung, or prostate cancer, presents with bone metastases (Hutchison et al 2012).  Health 
education is a fundamental nursing role, which has the potential to positively influence the 
patient experience of MSCC. 
 
Management of MSCC in the United Kingdom is guided by NICE (2018) algorithms. These 
frameworks offer a clear pathway of support and care for MSCC, but may encourage health 
care professionals to overlook the individual as they promote a ‘tick box’ and ‘one size fits all’ 
approach.  Treating patients as individuals and respecting their choices is a central tenet of 
effective nursing practice. The humanising framework enables nurses to consider individuals, 
rather than assigning them to a diagnostic group.  Humanising care focuses on the individual 
behind the ‘patient’, putting them at the heart of care and seeking what to understand their 
personal story and what it means to them to be human (Todres et al., 2009). This framework 
encourages open communication and care planning, respecting individual choice.  Nurses are 
ethically and professionally bound to respect every patient and to support their autonomy (NMC, 
28).  In the context of MSCC diagnosis, this can include rehabilitation interventions to promote 
independence, supportive care and/or palliative care, depending on the level of function on 
presentation and diagnosis, and/or the patient’s prognosis, whilst respecting their choices. 
 
NICE (2018) algorithms for management of MSCC highlight areas of patient dependency such 
as bowel and bladder management.  Eva et al.’s (2009) study reported that patients’ functional 
problems were managed well by nurses, but there was a failure to teach them self-care.  Health 
education is proposed as essential at the diagnosis of MSCC, based on the requirements of 
individual patients (Hutchison et al 2012).  The ‘Making Every Contact Count’ (MECC), brief 
intervention framework serves to promote health and reduce poor health through goal setting, 
based on meaningful brief conversations with patients and their families (Health Education 
England, 2018; Nelson et al., 2013).  MECC supports the development of a therapeutic 
relationship and in the context of MSCC can help to identify goals for maintaining and increasing 
independence where possible (including practical skills such as transferring/mobility, and 
intermittent self-catheterisation for bladder problems) and for end-of-life care as appropriate.   
  
Patients’ quality of life is clearly affected by symptoms of MSCC (Harris 2016; Warnock et al 
2008).  Patients became frustrated when a diagnosis of MSCC followed neurological deficits, 
including loss of mobility.  They reported frustration at not knowing what to look out for, 
therefore missing opportunities to seek medical help (Warnock and Tod 2014).  Where patients 
had sought help, they understood their ‘poor prognosis’ but felt frustrated at the length of time it 
had taken for MSCC to be diagnosed.   Some patients prefer not to think about the future, taking 
each day as it comes, which enables them to build ‘hope’ for the future (Harris 2016).  The use 
of care planning enables them to work towards independence, which helps to build hope for the 
future. 
 
Nursing should seek to support individuals’ choice through empowerment (NMC 2018).  Where 
MSCC results in a terminal diagnosis, referral to palliative care services is indicated.  
Discussions about choices at this time may include advance care planning, where patients are 
empowered to articulate their preferences and priorities for future care.  Nurses in oncology and 
palliative care usually get to know patients and their families, their values, concerns and 
thoughts, over a period of time, so should feel able and confident to hold advance care planning 
conversations (Anderson Head et al., 2018).  When patients present with MSCC as the first 
indication of an underlying malignancy however, a therapeutic relationship needs to be built 
from scratch.  This sensitive area of advance care planning requires advanced communication 
skills and appropriate experience as nurses need to understand when these conversations are, 
or are not, appropriate (Mullick et al., 2013). Ultimately, nurses should respect how much 
individuals want to know about their future and how much they want to be involved in decisions 
about their care (Nursing and Midwifery Council 2015; Peereboom and Coyle 2012).  Overall, if 
nurses are able to relate to every patient as an individual and understand the relevance of 
diagnosis and prognosis for them, in relation to MSCC, they are best placed to offer the 
optimum standard of sensitive and individualised care.   
   
Conclusion 
MSCC, with associated neurological deficit, is an oncological emergency that signals 
development of secondary cancer.  Early diagnosis (before the loss of mobility), enables prompt 
treatment and is therefore associated with the maintenance of physical function for a period of 
time.  There is a higher risk of MSCC development in people with primary breast, lung and 
prostate cancer.  Health education for these patients, about the significance of the onset of 
spinal pain, especially in the presence of neurological symptoms such as pins and needles or 
bladder dysfunction, at the time of discharge from follow-up care, or at least from the time of 
diagnosis of bone metastases, will enable prompt self-referral for medical advice.   
  
Quality of life is significantly impacted by MSCC.  Although frustrated at delays in diagnosis that 
impact on mobility and neurological function, patients with MSCC, in this literature review, 
describe a positive attitude to overcoming challenges, enabling hope.  The use of care planning 
and interventions to promote function help to maintain independence and build hope.  The 
prognosis of those with MSCC is poor and palliative care support is key to enhancing the 
experience of patients and facilitating choices for end-of-life care.  Individualised and 
humanising nursing care is central to empowering patients and nurses are ideally placed to 
engage in brief and meaningful communication interventions to develop a therapeutic 
relationship and deliver humanising care.  Since communications extend to advance care 
planning decisions, effective communication skills are essential.   
  
This literature review has explored the impact and management of MSCC.  Thematic analysis 
resulted in two themes of prognosis/survival time and independence vs dependence.  
Understanding the themes enables nurses to plan health education with those at risk to promote 
early diagnosis.  Following diagnosis, a humanising approach to care, combined with 
meaningful communication within a therapeutic relationship, can support patient choice in 
maintaining independence and in end-of-life care decisions.   
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